Price target
8.720.000.00%
The 1 analyst offering 1 year price forecasts for 2RZ have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings to 2RZ in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
2RZ EPS for the last quarter is 0.19 EUR despite the estimation of −0.37 EUR. In the next quarter EPS is expected to reach −0.48 EUR. Track more of POSEIDA THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter POSEIDA THERAPEUTICS INC revenue is expected to reach 14.49 M EUR. Check out POSEIDA THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, 2RZ price target is 8.72 EUR with a max estimate of 8.72 EUR and a min estimate of 8.72 EUR. Check if this forecast comes true in a year, meanwhile watch POSEIDA THERAPEUTICS INC stock price chart and keep track of the current situation with 2RZ news and stock market news.